Results 91 to 100 of about 40,178 (286)

Ticlopidine Induced Bullous Pemphigoid [PDF]

, 2009
Bullous pemphigoid (BP) is an acquired autoimmune disease that`s characterized by subepidermal vesicles and bullae. The etiology for BP is mostly idiopathic, but numerous observations have suggested the role of certain drugs in the occurrence of bullous ...
김수찬
core  

Recreational Allergic Contact Dermatitis to “Epoxy UV” Resins: A New Source of Exposure to Hidden (Meth)acrylates

Contact Dermatitis, EarlyView.
We report three cases of allergic contact dermatitis (ACD) caused by acrylic resins used in creative hobbies, rather than by epoxy resins, despite these products being incorrectly labelled as “epoxy UV” resins. ABSTRACT Background Several cases of contact allergy to epoxy resins used in creative hobbies have been reported in recent years but not to ...
Nadia Raison‐Peyron, Sylvain Caillol, Jean Luc Bourrain, Eva Ibeka, Claire Negrell   +4 more
wiley   +1 more source

Differential diagnostics of bullous dermatoses

, 2017
Bullous dermatoses are the diseases characterized by vesication and erosion of skin and/or mucos coats, production of autoantibodies against the structural components of epidermis and/or derma. The most frequent diseases of these disorders are pemphigus,
L. F. Znamenskaya, T. V. Abramova, A. A. Kubanov   +2 more
core   +1 more source

Development of Nummular Dermatitis Following Dupilumab Therapy Suggests a Th17‐Driven Mechanism

Australasian Journal of Dermatology, EarlyView.
Olga Pawlik, Michelle McRae
wiley   +1 more source

Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He, Shaymaa Hegazy, Phyu P. Aung, Priyadharsini Nagarajan, Fiorinda Muhaj, Adrienne N. Choksi, Ana M. Ciurea, Kelly C. Nelson, Doina Ivan, Carlos A. Torres‐ Cabala, Victor G. Prieto, Jonathan L. Curry   +11 more
wiley   +1 more source

JAK Inhibitors for Treatment of Pyoderma Gangrenosum and Sweet Syndrome: A Systematic Review of Published Case Reports

Dermatology Research and Practice
Neutrophilic dermatoses, including pyoderma gangrenosum (PG) and Sweet syndrome (SS), are inflammatory disorders characterized by neutrophilic infiltration without infection. Conventional therapies are often inadequate.
Seyed Mohammad Vahabi, Sama Heidari, Yalda Farahmand, Elnaz Pourgholi, Nika Kianfar, Huria Memari, Farzad Esmaeili, Saeed Bahramian, Ifa Etesami, Mahshid Sadat Ansari   +9 more
doaj   +1 more source

Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot‐Leyden Crystals

Allergy, EarlyView.
Janik Fleißner, Tassilo Dege, Sandrine Benoit, Matthias Goebeler, Andreas Kerstan   +4 more
wiley   +1 more source

Bullous Eruption Associated With Loncastuximab Tesirine in a Patient With Diffuse Large B‐Cell Lymphoma

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Loncastuximab tesirine (LT) is an antibody‐drug conjugate (ADC), a novel class of therapeutics that combines a target‐specific monoclonal antibody with a cytotoxic agent via a chemical linker. LT has been approved in the United States as therapy for relapsed or refractory diffuse large B‐cell lymphoma (DLBCL).
Daniella Jaguan, Cuong Nguyen, Jennifer N. Choi   +2 more
wiley   +1 more source

Pemphigus Vulgaris Activity Score and Assessment of Convergent Validity

Acta Medica Iranica, 2013
Pemphigus is a rare autoimmune blistering disease with different phenotypes. The evaluation of therapeutic interventions requires a reliable, valid and feasible to use measurement.
Cheyda Chams-Davatchi, Ziba Rahbar, Maryam Daneshpazhooh, Seyed Mohammad Ali Mortazavizadeh, Maryam Akhyani, Nafiseh Esmaili, Kamran Balighi   +6 more
doaj  

Gabapentin-Induced Bullous Pemphigoid

, 2017
Bullous pemphigoid is an autoimmune blistering dermatosis with separation of the epidermis from the dermis. This disease process is common among elderly patients and manifests with subepidermal vesicles and tense bullae.
Avram Flamm, Sarina Sachdev, Francois Dufresne   +2 more
core   +1 more source